Lifecore Biomedical to Be Acquired by Webster Equity Partners for Up to $663.7 Million

By Robb M. StewartLifecore Biomedical has agreed to be bought by Webster Equity Partners in a transaction valued at up to $663.7 million.The contract manufacturer of syringes and other injectable pharmaceutical products on Monday said it entered a definitive deal that will see an entity affiliated…